Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Solid Cancer × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Breast Neoplasms 17 Advanced Solid Tumors 11 Advanced Solid Tumor 11 Myelodysplastic Syndromes 9 Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Recurrence 5 Prostatic Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Triple Negative Breast Neoplasms 3 Solid Tumors 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Advanced Solid Tumour 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer (mCRPC) 2 Melanoma 2

Interventions

pembrolizumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07265921 2025-12-05

Solid Tumors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡